Research Publications 2023
Quantity
In 2023, a total of 90 articles were published, of which 44 (49%) were original research articles.
Figure 1. Number and type of Research Sector publications in 2023.
*Reviews include Reviews, Editorials, Comments, Letters to the Editor, Short Communications.
**Others refers to collaborative papers and publications where DDI staff are co-authors, but none of the actual research was done within DDI (excluding data sharing)
Quality
Impact Factor
The median Impact Factor (IF) of 2023 was 5.15 for total publications and 5.00 for original research articles. As for manuscripts published in key journals, i.e., journals with an IF ≥ 5, 50% of the total articles were published in key journals (Table 1).
Table 1. Median IF of total publications and publications in key journals, i.e., journals with an IF of ≥ 5 in 2023.
2023 | |
Total Publications | 90 |
Median IF | 5.15 |
% Key journals (IF ≥ 5) | 50% |
In 2023, the Research Sector produced manuscripts that were published in esteemed journals, such as Nature Medicine (IF, 82.9), Nature (IF, 64.8), and Circulation (IF, 37.8; Table 2).
Table 2. List of key journals (IF ≥ 5) publications from the Research Sector in 2023.
No. | Journal Name | IF | Number of Publications |
---|---|---|---|
1 | Nature Medicine | 82.9 | 1 |
2 | Nature | 64.8 | 1 |
3 | Circulation | 37.8 | 1 |
4 | Circulation Research | 20.1 | 1 |
5 | Nature Communications | 16.6 | 1 |
6 | Diabetes Care | 16.2 | 1 |
7 | Chemosphere | 8.8 | 1 |
8 | Environmental Research | 8.3 | 2 |
9 | Molecular Metabolism | 8.1 | 2 |
10 | Diabetes / Metabolism: Research and Reviews | 8 | 1 |
11 | Journal of Epidemiology and Global Health | 7.3 | 1 |
12 | Frontiers in Immunology | 7.3 | 3 |
13 | Canadian Journal of Cardiology | 6.2 | 1 |
14 | Cells | 6 | 4 |
15 | Stem Cells Translational Medicine | 6 | 1 |
16 | Nutrients | 5.9 | 1 |
17 | iScience | 5.8 | 1 |
18 | Journal of Clinical Endocrinology & Metabolism | 5.8 | 1 |
19 | Diabetes, Obesity, & Metabolism | 5.8 | 1 |
20 | International Journal of Molecular Sciences | 5.6 | 3 |
21 | Frontiers in Pharmacology | 5.6 | 3 |
22 | Frontiers in Cell and Developmental Biology | 5.5 | 1 |
23 | Frontiers in Endocrinology | 5.2 | 6 |
24 | Cancers | 5.2 | 1 |
25 | Frontiers in Public Health | 5.2 | 2 |
26 | Diabetes Research and Clinical Practice | 5.1 | 1 |
27 | Frontiers in Molecular Biosciences | 5 | 1 |
28 | Genes and Immunity | 5 | 1 |
Quartiles
In addition to the IF, rankings of journals in each subject category are divided into quartiles, which rank the journals from highest to lowest based on their IF. There are four quartiles: Q1, Q2, Q3 and Q4, which are explained in Table 3 below.
Table 3. Definition of quartile ranking of DDI publications
Quartile | Definition |
---|---|
Quartile 1 (Q1) | Denotes the top 25% of the IF distribution |
Quartile 2 (Q2) | Denotes middle-high position distribution (top 50% to top 25%) |
Quartile 3 (Q3) | Denotes middle-low position distribution (top 75% to top 50%) |
Quartile 4 (Q4) | Denotes lowest position (bottom 25% of the IF distribution) |
N/A | No available score for the journal, not listed |
In 2023, a higher percentage of publications from the Research Sector were published in Q1 journals (76% of % indexed), while 94% of articles were published in either Q1 or Q2 journals; the breakdown of publications in quartiles Q1 and Q1 + Q2 is shown in Figure 2.
Figure 2. 2023 Research Sector publications falling into Q1 and Q1 + Q2 quartile scores of % indexed.
Collaborative Publications
In 2023, the Research Sector collaborated with esteemed institutes from around the globe and produced high-impact publications. The number of articles published by international, national, and regional collaborators are shown in Table 4.
Table 4. Number of articles (and percentage of total publications) published with national, regional, and international collaborators by the Research Sector in 2023.
Number | Percentage of Total | |
---|---|---|
Total Publications | 90 | 100% |
National Collaborators | 35 | 39% |
Regional Collaborators | 20 | 22% |
International Collaborators | 68 | 76% |